out of 55 I think some are non evaluable
- Forums
- ASX - By Stock
- ATX
- Ann: Encouraging Updated Data from Pancreatic Cancer Trial
ATX
amplia therapeutics limited
Add to My Watchlist
2.50%
!
20.5¢

Ann: Encouraging Updated Data from Pancreatic Cancer Trial, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $77.59M |
Open | High | Low | Value | Volume |
20.5¢ | 20.5¢ | 20.0¢ | $125.6K | 617.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3846 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 108755 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16546 | 0.205 |
1 | 200000 | 0.200 |
3 | 112692 | 0.195 |
9 | 255727 | 0.190 |
6 | 175854 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 98406 | 2 |
0.215 | 208077 | 7 |
0.220 | 629281 | 6 |
0.225 | 201825 | 6 |
0.230 | 270616 | 7 |
Last trade - 10.15am 01/07/2025 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online